B. Kessel

870 total citations
17 papers, 562 citations indexed

About

B. Kessel is a scholar working on Neurology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, B. Kessel has authored 17 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 3 papers in Psychiatry and Mental health and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in B. Kessel's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). B. Kessel is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). B. Kessel collaborates with scholars based in United Kingdom, Spain and Italy. B. Kessel's co-authors include К. Ray Chaudhuri, Alexandra Rizos, Per Odin, Angelo Antonini, Pablo Martínez‐Martín, Cristian Falup‐Pecurariu, Anne Martin, Antonia Todorova, Monty Silverdale and Anna Sauerbier and has published in prestigious journals such as Movement Disorders, Age and Ageing and European Journal of Neurology.

In The Last Decade

B. Kessel

17 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kessel United Kingdom 9 434 104 83 79 47 17 562
Indu Subramanian United States 13 344 0.8× 53 0.5× 72 0.9× 51 0.6× 48 1.0× 33 484
Belén Frades Spain 13 370 0.9× 117 1.1× 177 2.1× 64 0.8× 79 1.7× 19 619
Martine Jeukens‐Visser Netherlands 11 241 0.6× 60 0.6× 132 1.6× 150 1.9× 57 1.2× 27 636
Rozina Bhimani United States 10 246 0.6× 47 0.5× 168 2.0× 48 0.6× 15 0.3× 28 435
N. G. A. Spliethoff‐Kamminga Netherlands 9 240 0.6× 53 0.5× 72 0.9× 48 0.6× 51 1.1× 9 366
Man Auyeung China 10 237 0.5× 58 0.6× 131 1.6× 86 1.1× 25 0.5× 14 383
F.R.J. Verhey Netherlands 8 332 0.8× 66 0.6× 310 3.7× 40 0.5× 118 2.5× 19 612
Ingrid H.W.M. Sturkenboom Netherlands 12 398 0.9× 52 0.5× 232 2.8× 28 0.4× 45 1.0× 19 585
Annette Hand United Kingdom 10 167 0.4× 46 0.4× 54 0.7× 65 0.8× 13 0.3× 30 277
Andy Tyerman United Kingdom 8 202 0.5× 467 4.5× 108 1.3× 92 1.2× 62 1.3× 19 613

Countries citing papers authored by B. Kessel

Since Specialization
Citations

This map shows the geographic impact of B. Kessel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kessel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kessel more than expected).

Fields of papers citing papers by B. Kessel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kessel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kessel. The network helps show where B. Kessel may publish in the future.

Co-authorship network of co-authors of B. Kessel

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kessel. A scholar is included among the top collaborators of B. Kessel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kessel. B. Kessel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rizos, Alexandra, Anna Sauerbier, Cristian Falup‐Pecurariu, et al.. (2020). Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey. Journal of Neural Transmission. 127(6). 875–879. 7 indexed citations
2.
Martínez‐Martín, Pablo, Alexandra Rizos, Angelo Antonini, et al.. (2018). First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire. European Journal of Neurology. 25(10). 1255–1261. 30 indexed citations
3.
Martínez‐Martín, Pablo, Alexandra Rizos, Angelo Antonini, et al.. (2018). Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease. Movement Disorders Clinical Practice. 6(1). 57–64. 19 indexed citations
4.
Rizos, Alexandra, Anna Sauerbier, Angelo Antonini, et al.. (2016). A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐ and long‐acting dopamine agonists. European Journal of Neurology. 23(8). 1255–1261. 72 indexed citations
5.
Rizos, Alexandra, Pablo Martínez‐Martín, Suvankar Pal, et al.. (2015). The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective. Parkinsonism & Related Disorders. 22. e41–e41. 2 indexed citations
6.
Chaudhuri, К. Ray, Alexandra Rizos, Claudia Trenkwalder, et al.. (2015). King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation. Movement Disorders. 30(12). 1623–1631. 192 indexed citations
7.
Rizos, Alexandra, Pablo Martínez‐Martín, Per Odin, et al.. (2014). Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study. Parkinsonism & Related Disorders. 20(11). 1231–1235. 73 indexed citations
8.
Rizos, Alexandra, B. Kessel, Pablo Martínez‐Martín, et al.. (2012). Early morning off periods in Parkinson's disease: Characterisation of non motor patterns and treatment effect: An international study. Research Portal (King's College London). 27. 3 indexed citations
9.
Rizos, Alexandra, Pablo Martínez‐Martín, Ana López, et al.. (2012). European multicentre survey of tolerability rates and impulse control behaviour trends of prolonged release dopamine agonists in young and old PD. 27. 7 indexed citations
10.
Rizos, Alexandra, Anne Martin, Inga Koch, et al.. (2011). 2.135 CHARACTERISING NON MOTOR PATTERNS OF EARLY MORNING OFF PERIODS IN PARKINSON'S DISEASE: AN INTERNATIONAL STUDY. Parkinsonism & Related Disorders. 18. S110–S110. 2 indexed citations
11.
Strathdee, Geraldine, et al.. (2011). Audit of fidelity of clinicians to the Mental Capacity Act in the process of capacity assessment and arriving at best interests decisions. Quality in Ageing and Older Adults. 12(3). 174–179. 7 indexed citations
12.
Rizos, Alexandra, Amy Martin, S. Tluk, et al.. (2011). 2.258 LONG ACTING DOPAMINE AGONISTS IN CLINICAL PRACTICE: A COMPARATIVE MULTICENTRE EUROPEAN SURVEY IN YOUNG AND OLD PD. Parkinsonism & Related Disorders. 18. S129–S130. 2 indexed citations
13.
Shotbolt, Paul, et al.. (2010). Three cases of delusional parasitosis caused by dopamine agonists. Clinical and Experimental Dermatology. 35(7). 740–742. 31 indexed citations
14.
Martin, Anne, et al.. (2007). Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital. Parkinsonism & Related Disorders. 13(8). 539–540. 44 indexed citations
15.
Kishore, Bhuvan, et al.. (2007). Hypokalaemic rhabdomyolysis. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 44(3). 308–311. 15 indexed citations
16.
Kessel, B.. (2006). A case of hedonistic homeostatic dysregulation. Age and Ageing. 35(5). 540–541. 5 indexed citations
17.
Kessel, B.. (2001). Sexuality in the older person. Age and Ageing. 30(2). 121–124. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Indu Subramanian Breakdown of academic impact, for papers by Belén Frades Breakdown of academic impact, for papers by Martine Jeukens‐Visser Breakdown of academic impact, for papers by Rozina Bhimani Breakdown of academic impact, for papers by N. G. A. Spliethoff‐Kamminga Breakdown of academic impact, for papers by Man Auyeung Breakdown of academic impact, for papers by F.R.J. Verhey Breakdown of academic impact, for papers by Ingrid H.W.M. Sturkenboom Breakdown of academic impact, for papers by Annette Hand Breakdown of academic impact, for papers by Andy Tyerman
Rankless by CCL
2026